TNFSF11 and cancer: In particular, 89Zr-anti-RANKL radioimmunoconjugates were synthesized in a reproducible way, characterized for antigen affinity and optimal biodistribution, and validated as markers of RANKL expression and heterogeneity in the TME in human cancer xenograft models.